Neuralink says FDA designated its Blindsight implant
Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.
Neuralink says the FDA designated its Blindsight implant as a 'breakthrough device'
Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore blind people's sight.
Neuralink Blindsight receives FDA Breakthrough Device Designation for visually impaired patients
With Blindsight now receiving the FDA’s Breakthrough Device Designation, Neuralink looks set to push forward with technology to help those with vision disabilities as well. Stay tuned as we continue to follow this story for further updates.
Elon Musk's Neuralink gets FDA 'breakthrough device' designation: restores vision to the blind
Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.
Neuralink secures FDA approval to test futuristic device that could enable vision in the blind
Neuralink recently announced that it has received "Breakthrough Device Designation" from the FDA for Blindsight, a device designed to restore vision to those who can no
Neuralink’s ‘Blindsight’ Device Receives FDA Breakthrough Designation
Elon Musk's brain-chip company Neuralink has received the FDA’s "breakthrough device" designation for its experimental vision-restoring implant, Blindsight.
Neuralink Brain Implant Wins an FDA Nod to Tackle Blindness
The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.
"If This Device Lives Up...": Anand Mahindra On Elon Musk's Neuralink Blindsight Device
Industrialist Anand Mahindra on Thursday praised Elon Musk's Blindsight device from its brain-chip startup Neuralink, saying that it would be the tech mogul's "most enduring gift to humankind".
BridgeBio Says FDA Grants Breakthrough Therapy Designation To Oral Infigratinib For Achondroplasia
Biopharmaceutical company BridgeBio Pharma, Inc. (BBIO) announced Tuesday that the US FDA has granted Breakthrough Therapy ...
Spectrum News NY14d
FDA gives special designation to Neuralink brain chip designed to allow blind to see
A device that could potentially allow blind people — even those born without the sense of sight — to see has received the U.S. Food and Drug Administration’s “breakthrough device ...
MarketWatch5d
BridgeBio Gets FDA Breakthrough Therapy Designation for Achondroplasia Treatment
BridgeBio said it received breakthrough therapy designation from the U.S. Food and Drug Administration for infigratinib, a treatment under development for children with achondroplasia. The ...
Benzinga.com4d
Neuralink's 'Blindsight' Device Receives FDA Breakthrough Designation
Elon Musk’s brain-chip company Neuralink has received the FDA's “breakthrough device” designation for its experimental vision-restoring implant, Blindsight. The designation, announced on ...
Yahoo Finance4d
Neuralink obtains breakthrough designation from FDA for Blindsight device
Neurotechnology company Neuralink has secured a breakthrough device designation from the US Food and Drug Administration (FDA) for its Blindsight device. This advanced technology promises to ...